Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC

@inproceedings{Lachin2015EffectOI,
  title={Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC},
  author={John M Lachin and N. H. White and Dean P. Hainsworth and Wanjie Sun and Patricia A. Cleary and David Matthew Nathan},
  booktitle={Diabetes},
  year={2015}
}
The Diabetes Control and Complications Trial (DCCT) demonstrated that a mean of 6.5 years of intensive therapy aimed at near-normal glucose levels reduced the risk of development and progression of retinopathy by as much as 76% compared with conventional therapy. The Epidemiology of Diabetes Interventions and Complications study (EDIC) observational follow-up showed that the risk of further progression of retinopathy 4 years after the DCCT ended was also greatly reduced in the former intensive… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Zinman B, for the DCCT/EDIC Research Group. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years

DM Nathan, M Bayless, +4 authors G Lorenzi
Diabetes • 2013
View 2 Excerpts
Highly Influenced

Effect of prior intensive therapy in type 1 diabetes on 10 - year progression of retinopathy in the DCCT / EDIC : comparison of adults and adolescents

DM Nathan, M Bayless, P Cleary
Diabetes • 2010

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

CL Martin, J Albers, WH Herman
JAMA • 2002

Similar Papers

Loading similar papers…